Dosidal · Canada
FLUORESCEIN
Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.
| Market | Canada |
|---|---|
| Record | ca:authorisation:din:02027089:16627 (version 1) |
| Level | authorisation |
| Pack code | not anchored |
| Identifiers | ca-din: 02027089 ca-dpd-drug-code: 16627 |
| Source authority | Health Canada |
| Read date | 2026-11-15T06:54:55Z |
| authorisation status | lifecycle: current status: DORMANT status_date: 2018-07-10 status_date_as_published: 10-JUL-2018 status_history: date: 2017-05-08 status: MARKETED; date: 2017-05-08 status: APPROVED; date: 2018-07-10 status: APPROVED; date: 2018-07-10 status: MARKETED; date: 2018-07-10 status: DORMANT; date: 2017-07-18 status: DORMANT; date: 1994-12-31 status: MARKETED state: current · read 2026-11-15T06:54:55Z · source: Health Canada - Drug Product Database page |
| controlled status | controlled: False state: current · read 2026-11-15T06:54:55Z · source: Health Canada - Drug Product Database page |
| identity | atc: V04CX brand_name: FLUORESCEIN class: Human companies: PHARMA STULLN INC. din: 02027089 drug_code: 16627 extract_set: dormant forms: SOLUTION ingredients: ingredient: FLUORESCEIN SODIUM strength: 100 MG packaging_as_published: product_information: 5ML routes: INTRAVENOUS state: current · read 2026-11-15T06:54:55Z · source: Health Canada - Drug Product Database page |
| prescription class | class: non_prescription (ethical) schedules: ETHICAL state: current · read 2026-11-15T06:54:55Z · source: Health Canada - Drug Product Database page |
| Signature | ES256 over JCS, key dosidal-record-1.9dbf5d53sRWywBDf4tRbKUXJrUFSCYM4fJhhqOSi7Z_LVsOrEz3lUFPkto2jB1C5BAc9dO0rf663KGiduCogMaisuAfhMAVerify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json |
JSON: https://dosidal-api.ai/v1/records/ca:authorisation:din:02027089:16627 · Same medicine in other markets · Dosidal